Diseases [C] » Infections [C01] » Sepsis
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Inflammation » Systemic Inflammatory Response Syndrome » Sepsis
Description
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. MeSH
Hierarchy View
Subtype Terms (6)
Bacteremia
58 drugs (43 approved, 15 experimental)
Fungemia
12 drugs (9 approved, 3 experimental)
Neonatal Sepsis
37 drugs (25 approved, 12 experimental)
Parasitemia
13 drugs (10 approved, 3 experimental)
Shock, Septic
146 drugs (93 approved, 53 experimental)
Viremia
9 drugs (7 approved, 2 experimental)
Approved Indicated Drugs (16)
Phase 4 Indicated Drugs (80)
Phase 3 Indicated Drugs (68)
Phase 2 Indicated Drugs (52)
Phase 1 Indicated Drugs (21)
Other Experimental Indicated Drugs (40)
Organization Involved with Phase 4 Indications (74)
Association Pour La Promotion A Tours De La Reanimation Medicale
Canadian Institutes of Health Research (CIHR)
Katholieke Universiteit Leuven
Los Angeles Biomedical Research Institute
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
National Health and Family Planning Commission, P.R.China
National Hospital Organization Kyoto Medical Center
National Institute for Health Research, United Kingdom
National Institute of General Medical Sciences (NIGMS)
Sir Takhtasinhji General Hospital
State Hospital, Baden, Switzerland
Sunnybrook Health Sciences Centre
Tianjin Chase Sun Pharmaceutical Co., LTD
Organization Involved with Phase 3 Indications (133)
All India Institute of Medical Sciences
Aragon Institute of Health Sciences
Aristotle University of Thessaloniki
Bill and Melinda Gates Foundation
Centers for Disease Control and Prevention (CDC)
Children's National Medical Center
Harborview Injury Prevention and Research Center
Hellenic Institute for the Study of Sepsis
Hormozgan University of Medical Sciences
Hospital general Universitario de Ciudad Real
Hospital Italiano de Buenos Aires
IMSS Hospital General de Zona 11
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Institute Tropical Medicine Belgium and MRC Unit in The Gambia
Institut National de la Santé Et de la Recherche Médicale, France
International Center for Diarrheal Disease Research
Lata Medical Research Foundation, Nagpur, India
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
Postgraduate Institute of Medical Education and Research
Scandinavian Critical Care Trials Group
Shanghai University of Traditional Chinese Medicine
United States Agency for International Development
Universidad Nacional de La Plata
University of California, Los Angeles
University of Castilla-La Mancha
University of Medicine and Dentistry of New Jersey
University of Naples Frederico II
University of North Carolina at Chapel Hill
University of Southern California
University Teaching Hospital, Lusaka, Zambia
Vardhman Mahavir Medical College
Vita-Salute University of Milano. Italy
Zhejiang Hisun Pharmaceutical Co. Ltd.
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (80)
Bambino Gesù Hospital and Research Institute
Boryung Pharmaceutical Company
Community Medical Center, Toms River, NJ
Consorzio per Valutazioni Biologiche e Farmacologiche
Department of Health and Family Welfare, Orissa
Federal University of Rio Grande do Sul
Hamilton Health Sciences Corporation
Instituto Mexicano del Seguro Social
Ispat General Hospital, Rourkela
Justus Liebig University Giessen
Moorgreen Hospital, Southampton
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Northern Health and Social Care Trust
Northern Hospital, Epping, Victoria, Australia
People's Liberation Army of China
Pharmaceutical Research Associates, Inc. (PRA)
Saint Francis Hospital and Medical Center
Second Military Medical University
SYNAPSE Research Management Partners S.L
Technical University of Dresden
Topiwala National Medical College
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (35)
Guangdong Provincial Hospital of Traditional Chinese Medicine
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
